New Market - January 31, 2014
Moberg Pharma gets approval in United Arab Emirates
The company’s partner Leosons International has received approval for Kerasal Nail in UAE. According to Moberg Pharma, launch preparations of the product will start immediately. In October 2013 a distribution agreement was signed sixteen markets in the MENA region (Middle East and North Africa). “We signed the distribution agreement with Leosons just three months ago. The rapid […]
MedTech Business - January 31, 2014
RaySearch gets first UK order
RaySearch Laboratories has won a contract to supply its RayStation treatment planning system to Tayside Cancer Centre, Ninewells Hospital & Medical School in Dundee, UK. This will be the first clinical installation of RayStation in the United Kingdom. Ninewells offers all forms of cancer therapy and treats approximately 1400 new cancer patients annually, states RaySearch. The […]
Drug Development Pharma - January 30, 2014
AstraZeneca closes India R&D unit
The drug maker is to close its Avishkar R&D centre in Bangalore, India, and move parts of its research to Great Britain. The move that will impact 168 employees and early-stage research on tuberculosis and malaria. The decision to shut the R&D centre is said to be part of an ongoing global restructuring exercise. The pharmaceutical development […]
Uncategorized - January 30, 2014
New mechanism for genome unpacking in stem cells identified
Scientists at Karolinska Institutet and Gurdon Institute in Cambridge, United Kingdom have identified a novel mechanism allowing pluripotent stem cells to maintain their genome in an unpacked state. Embryonic stem cells and induced pluripotent stem cells have the ability to give rise to all cell types present in the adult body. In order to maintain […]
Drug development - January 23, 2014
Kancera starts ROR study
The company has announced that it is initiating the development of a vaccine directed against ROR. Kancera’s strategy is, according to the Karolinska Institutet Science Park company, to use its future small-molecule ROR inhibitors as a first line treatment for the disease and thereafter follow with a prophylactic ROR vaccine to prevent relapse. The initiative is motivated by […]
Biotech article - January 23, 2014
Pharmbiotech Oy to launch biomass production
Russian Biopharmos’ Finnish subsidiary will start biomass production in Finland. The ambition is to initiate biomass production for the medical and food industries in Hamina, south-eastern Finland, by the end of 2014. The project investment is estimated at EUR 2 million. Installation of equipment at the plant located near the Port of Hamina could start in March, […]
